REPL - Financial Reports List - Replimune Group, Inc. - IntrinsicAlpha

Replimune Group, Inc. REPL

Healthcare - Biotechnology - NASDAQ - US

$ 8.765

9.63 %

$ 675 M

Market Cap

-2.86

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q3	8-K	2024-12-31	0.00%	-29.77%	-16.77%
Quarterly Report	Q2	8-K	2024-09-30	0.00%	11.64%	7.70%
Quarterly Report	Q1	8-K	2024-06-30	0.00%	-8.51%	-3.09%
Quarterly Report	Q4	8-K	2024-03-31	0.00%	-11.85%	-10.87%
Annual Report	FY	10-K	2024-03-31	0.00%	-23.82%	-32.58%
Quarterly Report	Q3	8-K	2023-12-31	0.00%	-28.80%	-35.82%
Quarterly Report	Q2	8-K	2023-09-30	0.00%	-39.31%	-53.52%
Quarterly Report	Q1	8-K	2023-06-30	0.00%	-17.28%	-36.14%
Quarterly Report	Q4	8-K	2023-03-31	0.00%	-55.35%	-65.67%
Annual Report	FY	10-K	2023-03-31	0.00%	-47.65%	-49.67%

1